Sanjivani Paranteral Limited (BOM:531569)

India flag India · Delayed Price · Currency is INR
164.05
-3.00 (-1.80%)
At close: Apr 28, 2026
-31.17%
Market Cap 2.02B
Revenue (ttm) 736.34M
Net Income (ttm) 82.71M
Shares Out 12.28M
EPS (ttm) 6.60
PE Ratio 24.84
Forward PE n/a
Dividend 0.50 (0.30%)
Ex-Dividend Date n/a
Volume 4,580
Average Volume 5,754
Open 167.05
Previous Close 167.05
Day's Range 163.00 - 174.00
52-Week Range 132.50 - 268.80
Beta -0.53
RSI 46.00
Earnings Date May 8, 2026

About Sanjivani Paranteral

Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering ... [Read more]

Industry Pharmaceutical Preparations
Founded 1994
Employees 40
Stock Exchange Bombay Stock Exchange
Ticker Symbol 531569
Full Company Profile

Financial Performance

In fiscal year 2025, Sanjivani Paranteral's revenue was 700.99 million, an increase of 28.83% compared to the previous year's 544.11 million. Earnings were 80.97 million, an increase of 31.34%.

Financial Statements

News

Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

2 months ago - GuruFocus

Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

5 months ago - GuruFocus